Mersana Therapeutics
Signal active
Organization
Contact Information
Overview
Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications.
It was founded in 2005 and headquartered in Cambridge, Massachusetts.
About
Industries
Biotechnology, Health Care, Medical, Therapeutics
Founded
2005
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Mersana Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $125.9B in funding across 192 round(s). With a team of 101-250 employees, Mersana Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Mersana Therapeutics, raised $21.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
12
Investors
8
Lead Investors
0
Total Funding Amount
$655.6M
Details
4
Mersana Therapeutics has raised a total of $655.6M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2016 | Late Stage Venture | 33.0M | ||
| 2015 | Early Stage Venture | 35.0M | ||
| 2014 | Early Stage Venture | 14.5M | ||
| 2012 | Early Stage Venture | 27.0M |
Investors
Mersana Therapeutics is funded by 30 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Mersana Therapeutics | - | FUNDING ROUND - Mersana Therapeutics | 21.0M |
| F-Prime Capital | - | FUNDING ROUND - F-Prime Capital | 21.0M |
| Mersana Therapeutics | - | FUNDING ROUND - Mersana Therapeutics | 21.0M |
| Eight Roads Ventures | - | FUNDING ROUND - Eight Roads Ventures | 21.0M |
Recent Activity
There is no recent news or activity for this profile.